Dr. Jason P. Glotzbach, MD

Media Releases

University of Utah's Dr. Jason Glotzbach Takes Aortic Care to New Heights

Dr. Jason Glotzbach is at the forefront of innovative treatments for aortic disease, serving as an Assistant Professor of Surgery at the University of Utah. With a distinguished background in adult cardiac surgery, his expertise extends to the intricate realm of aortic pathology, encompassing aortic dissection, aortic aneurysm, and beyond.

A graduate of Princeton University and the Tulane University School of Medicine, his journey led him through rigorous training at the University of North Carolina and Columbia University, culminating in his esteemed position within the University of Utah's Division of Cardiothoracic Surgery. Since joining the faculty in 2016, he has been a beacon of excellence in the field, serving as the Co-Director of the University of Utah Aortic Disease Program.

As the Co-Director of the Aortic Disease Program, Dr. Glotzbach spearheads a multidisciplinary team dedicated to providing comprehensive care for patients with diverse aortic disorders. His specialization in congenital bicuspid aortic valve disease and connective tissue disorders, such as Marfan Syndrome, showcases his commitment to addressing complex conditions with precision and compassion.

Beyond his clinical duties, he is a fervent advocate for research and innovation. Engaged in pioneering studies on the genetic underpinnings of aortic aneurysms and dissections, he is at the vanguard of advancing our understanding of aortic disease. Notably, his leadership as the Principal Investigator of the TAVR low-risk trial underscores his dedication to exploring cutting-edge therapies for structural heart valve disease.

With a rich tapestry of publications in basic science and surgical literature, Dr. Glotzbach's contributions resonate far beyond the operating room, shaping the future of cardiovascular care. His expertise in minimally invasive surgery for valve repair, valve replacement, and aortic reconstruction underscores his unwavering commitment to enhancing patient outcomes through innovative techniques.

Recommended Articles

• Alternative Remedies to Treat Cardiovascular Diseases

  Herbal Treatment of the heart has been used by mankind for centuries and has shown an excellent effect. Especially effective was the use of medicinal plants in the case of chronic diseases, such as atherosclerosis and hypertension, where treatment involves a particular duration and a comprehensive...

• Congestive Heart Failure: What is Coronary Artery Bypass Surgery (CABG)?

  Congestive Heart Failure is the leading cause of emergency hospitalization among people aged over sixty. It is a condition where the heart is inefficient in pumping the required amount of blood to the other parts of the body. This inefficiency can sometimes be so severe that it can impair the...

• Are There Benign and Malignant Tumors of the Heart?

  It is a well-known fact that in the body, in various tissues due to various reasons, neoplasms sometimes appear in the form of tumor growths. The heart is not an exception. The tumor growth can be benign and malignant. Therefore, there are two types of the heart tumors.Benign tumors These do not...

• What Is an Arrhythmia?

  An arrhythmia is the violations of the frequency, rhythm, and sequence of heart contractions.Why do arrythmias occur?...

• Different Types of Heart Doctors Explained

  IntroductionDoctors who specialize in the diagnosis and treatment of conditions or diseases of the cardiovascular system (the heart and blood vessels) are called heart doctors or cardiologists. These specialists are trained to identify, treat, and help prevent heart issues. There are also different...

• Atrial Fibrillation: What is a Catheter Ablation?

  Atrial fibrillation - also known as AF or a-fib - is a medical condition that affects the rhythm of the heart. Problems that affect the rhythm of the heart cause a condition known as arrhythmia. This condition often causes irregular blood flow. It is quite common, with more than 200,000 cases in the...